Current issues in treatment of respiratory infections

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

The management of community-acquired pneumonia and acute exacerbations of chronic bronchitis is costly and fraught with error. Implementing widespread changes in the management of these common lower respiratory tract infections will require practical guidelines that can be applied in the clinic setting. Primary care physicians and specialists are also facing new respiratory infections. Atypical pathogen infection may be a contributor to disease pathogenesis in asthma, and antimicrobial treatment may be considered in some patients. Tuberculosis and other lung infections are increasingly seen in patients with rheumatoid arthritis or Crohn disease who are treated with anti-tumor necrosis factor therapy. The severe acute respiratory syndrome and avian flu are reminding the medical community of the global health and economic consequences of novel respiratory infections.

Original languageEnglish (US)
Pages (from-to)167-173
Number of pages7
JournalInfections in Medicine
Volume21
Issue number4
StatePublished - Apr 2004

Fingerprint

Respiratory Tract Infections
Severe Acute Respiratory Syndrome
Influenza in Birds
Chronic Bronchitis
Primary Care Physicians
Infection
Crohn Disease
Rheumatoid Arthritis
Pneumonia
Tuberculosis
Therapeutics
Asthma
Tumor Necrosis Factor-alpha
Economics
Guidelines
Lung
Global Health

Keywords

  • Acute exacerbations of chronic bronchitis
  • Community-acquired
  • Pneumonia
  • Severe acute respiratory syndrome
  • Tumor necrosis factor

ASJC Scopus subject areas

  • Microbiology (medical)

Cite this

Current issues in treatment of respiratory infections. / Kenyon, Nicholas; Albertson, Timothy E.

In: Infections in Medicine, Vol. 21, No. 4, 04.2004, p. 167-173.

Research output: Contribution to journalArticle

@article{9063761991bb453eb76f8e2bce27caa7,
title = "Current issues in treatment of respiratory infections",
abstract = "The management of community-acquired pneumonia and acute exacerbations of chronic bronchitis is costly and fraught with error. Implementing widespread changes in the management of these common lower respiratory tract infections will require practical guidelines that can be applied in the clinic setting. Primary care physicians and specialists are also facing new respiratory infections. Atypical pathogen infection may be a contributor to disease pathogenesis in asthma, and antimicrobial treatment may be considered in some patients. Tuberculosis and other lung infections are increasingly seen in patients with rheumatoid arthritis or Crohn disease who are treated with anti-tumor necrosis factor therapy. The severe acute respiratory syndrome and avian flu are reminding the medical community of the global health and economic consequences of novel respiratory infections.",
keywords = "Acute exacerbations of chronic bronchitis, Community-acquired, Pneumonia, Severe acute respiratory syndrome, Tumor necrosis factor",
author = "Nicholas Kenyon and Albertson, {Timothy E}",
year = "2004",
month = "4",
language = "English (US)",
volume = "21",
pages = "167--173",
journal = "Infections in Medicine",
issn = "0749-6524",
publisher = "CMP Healthcare Media LLC",
number = "4",

}

TY - JOUR

T1 - Current issues in treatment of respiratory infections

AU - Kenyon, Nicholas

AU - Albertson, Timothy E

PY - 2004/4

Y1 - 2004/4

N2 - The management of community-acquired pneumonia and acute exacerbations of chronic bronchitis is costly and fraught with error. Implementing widespread changes in the management of these common lower respiratory tract infections will require practical guidelines that can be applied in the clinic setting. Primary care physicians and specialists are also facing new respiratory infections. Atypical pathogen infection may be a contributor to disease pathogenesis in asthma, and antimicrobial treatment may be considered in some patients. Tuberculosis and other lung infections are increasingly seen in patients with rheumatoid arthritis or Crohn disease who are treated with anti-tumor necrosis factor therapy. The severe acute respiratory syndrome and avian flu are reminding the medical community of the global health and economic consequences of novel respiratory infections.

AB - The management of community-acquired pneumonia and acute exacerbations of chronic bronchitis is costly and fraught with error. Implementing widespread changes in the management of these common lower respiratory tract infections will require practical guidelines that can be applied in the clinic setting. Primary care physicians and specialists are also facing new respiratory infections. Atypical pathogen infection may be a contributor to disease pathogenesis in asthma, and antimicrobial treatment may be considered in some patients. Tuberculosis and other lung infections are increasingly seen in patients with rheumatoid arthritis or Crohn disease who are treated with anti-tumor necrosis factor therapy. The severe acute respiratory syndrome and avian flu are reminding the medical community of the global health and economic consequences of novel respiratory infections.

KW - Acute exacerbations of chronic bronchitis

KW - Community-acquired

KW - Pneumonia

KW - Severe acute respiratory syndrome

KW - Tumor necrosis factor

UR - http://www.scopus.com/inward/record.url?scp=2342549267&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=2342549267&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:2342549267

VL - 21

SP - 167

EP - 173

JO - Infections in Medicine

JF - Infections in Medicine

SN - 0749-6524

IS - 4

ER -